EndoSense: Continuous Real-Time Monitoring of Health Markers in Endocrine and Metabolic Disorders
EndoSense: Continuous Real-Time Monitoring of Health Markers in Endocrine and Metabolic Disorders
Active, not recruiting · NCT07727356 · Registry updated 2026-07-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| EndoSense: Continuous Real-Time Monitoring of Health Markers in Endocrine and Metabolic Disorders | Body Weight, Cushing syndrome, Nutritional and Metabolic Diseases, Overweight, Paraneoplastic Endocrine Syndromes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, adrenal gland disorder, adrenal gland hyperfunction, cardiovascular disorder, ectopic ACTH secretion syndrome, endocrine system disorder, hyperaldosteronism, hypertensive disorder, neoplasm, nutritional disorder, obesity disorder, overnutrition, paraneoplastic syndrome, primary aldosteronism, vascular disorder | Active, not recruiting | Not applicable | 2026-07-27 | NCT07727356 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ETH Zurich (Switzerland) | 12 |
| Felix Beuschlein | 2 |
| Pontificia Universidad Catolica de Chile | 49 |
| University Hospital, Zürich | 50 |
| University of Zurich | 188 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University Hospital Zürich | Zurich | Switzerland | 7 |